MSR12 Analysis of Long-Term Survivorship (LTS) Rates for Stage 2B/2C Melanoma Using Published Real-World Data (RWD) and Data From Randomized Controlled Trials (RCTS)
Year: 2023
Type: conference-abstract
Source: Value in Health
Authors: O. Alagoz, A. Winge-Main, S. Srinivasan, M. Dyer, R. Wolf, S.H. Thybo, J.R. May, A. Moshyk, M. Kurt
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: bronze
OpenAlex ID: W4390129419